Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics, January 2014 (p100)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

2971-3010 of about 30 000 reports
Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Barr Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Barr Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Pharmaceutical Product Development, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Pharmaceutical Product Development, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Anacor Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Anacor Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
United Drug Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

United Drug Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Drug and Medication
Access Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Access Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Teva Pharmaceutical Industries, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Teva Pharmaceutical Industries, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Dong-A Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Dong-A Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Ligand Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Ligand Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Myriad RBM (formerly Rules-Based Medicine, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Myriad RBM (formerly Rules-Based Medicine, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Drug and Medication
Shanghai Pharmaceutical Group Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Shanghai Pharmaceutical Group Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Rexahn Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Rexahn Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Optimer Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Optimer Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Portola Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Portola Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Regulus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Regulus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytori Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • January 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Insys Therapeutics, Inc. (INSY) - Financial and Strategic SWOT Analysis Review

Insys Therapeutics, Inc. (INSY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2014
  • by Global Data

Insys Therapeutics, Inc. (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled ...

  • Industries : Therapy
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2014
  • by Global Data

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has ...

  • Industries : Pharmaceutical
  • Countries : India
Amphastar Pharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

Amphastar Pharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : United States
Britannia Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

Britannia Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
Sucampo Pharmaceuticals, Inc. (Symbol:SCMP) SWOT Analysis, Strategy, Revenues and Profits

Sucampo Pharmaceuticals, Inc. (Symbol:SCMP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
Analysis of Gilead Sciences

Analysis of Gilead Sciences

  • $ 300
  • Company report
  • March 2014
  • by Aruvian's R'search

Based in the United States, Gilead Sciences is a global leader in the marketing and development of anti-infective drugs. The company has approved products for the treatment of Hepatitis B & C, HIV/AIDS, ...

  • Industries : Drug and Medication
  • Countries : United States
JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis Review

JCR Pharmaceuticals Co., Ltd. (4552) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2014
  • by Global Data

Summary This comprehensive SWOT profile of JCR Pharmaceuticals Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Pharmaceutical
CMG Pharmaceutical Co., Ltd. (058820) - Financial and Strategic SWOT Analysis Review

CMG Pharmaceutical Co., Ltd. (058820) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2014
  • by Global Data

Summary This comprehensive SWOT profile of CMG Pharmaceutical Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Pharmaceutical
Portola Pharmaceuticals, Inc. (PTLA) - Financial and Strategic SWOT Analysis Review

Portola Pharmaceuticals, Inc. (PTLA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2014
  • by Global Data

Summary This comprehensive SWOT profile of Portola Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Pharmaceutical
Broad Intelligence International Pharmaceutical Holdings Limited (Symbol:1149) SWOT Analysis, Strategy, Revenues and Profits

Broad Intelligence International Pharmaceutical Holdings Limited (Symbol:1149) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical

» View Public Reports

About 41 000 reports

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...


» Read our Company Profiles

About 600 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.